Evidence map›Paper›PMID 42889220›Full record

ArticleNutrition research and practice2026

Yin Jiang, Bo Li, Zheng Zhang, Jie Yang, JianE Chen, Yan Li

Abstract read
In one paragraph

Article in Nutrition research and practice, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Yin JiangDepartment of Clinical Laboratory, The First People's Hospital of Fuyang District, Hangzhou 311400, China.ORCID https://orcid.org/0009-0003-4141-8825
Bo LiDepartment of Clinical Laboratory, The First People's Hospital of Fuyang District, Hangzhou 311400, China.ORCID https://orcid.org/0009-0005-1995-2145
Zheng ZhangDepartment of Clinical Laboratory, Fuchun Branch of The First People's Hospital of Fuyang District, Hangzhou 311400, China.ORCID https://orcid.org/0009-0003-2710-2373
Jie YangDepartment of Clinical Laboratory, The First People's Hospital of Fuyang District, Hangzhou 311400, China.ORCID https://orcid.org/0009-0000-6226-3963
JianE ChenDepartment of Internal Medicine-Neurology, The First People's Hospital of Fuyang District, Hangzhou 311400, China.ORCID https://orcid.org/0009-0006-4139-2575
Yan LiDepartment of AIDS Tuberculosis Prevention and Control, Disease Control Center of Fuyang District, Hangzhou 311402, China.ORCID https://orcid.org/0009-0003-7241-0623

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND/

objectivesCerebral ischemia-reperfusion injury (CIRI) is characterized by oxidative stress (OS) and ferroptosis. MATERIALS/

methods

resultsA CME pretreatment significantly restored the cell viability, reduced apoptosis, and suppressed OS and ferroptosis in OGD/R-induced H19-7 cells, as evidenced by decreased ROS, MDA, apoptosis, lipid peroxidation, and Fe

conclusionCME alleviates CIRI by inhibiting OS and ferroptosis via the miR-144/Nrf2 pathway, providing novel insights into CIRI treatment strategies.

Indexed as

Cerebral ischemiaChrysanthemumferroptosisoxidative stressreperfusion injury

Identifiers

PMID42889220
PMCPMC13669482

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.